TBD

Stacey Davidson is Head of Content and Strategy at Cuttsy+Cuttsy. With over 20 years’ experience across healthcare and agency roles, she specialises in health literacy and behavioural science, supporting teams to translate complex clinical science into communication that is clearer, more human and more workable in real‑world trial settings. At Patients as Partners Europe, Stacey is delivering two sessions. The first introduces The Experience Gap - a research‑grounded roadmap outlining the clinical trial journey end‑to‑end, identifying the critical human moments that influence trust, motivation and retention, and translating insight into practical communication action. Her second session, co‑presented with AstraZeneca, explores a communications framework designed to help sites better support patients, demonstrating how thoughtful communication can reduce burden all round, and improve trial experiences for participants.

Sarah is an experienced medical communications professional with over two decades in the industry, including 24 years at Parexel. She brings a deep understanding of the medical communications landscape, underpinned by 12 years of expertise in editorial roles spanning proofreading, copy-editing, and project management.

Over the past 12 years, Sarah has specialised in Patient and Site Communications, where she has played a key role in shaping patient-centric, inclusive, and family-focused communication strategies. She is highly skilled in developing tailored content for diverse audiences, capturing authentic patient voice, and contributing to branding and creative development. Her experience spans the full lifecycle of communications, including strategic input, content creation, translation, and both print and digital production. Sarah is also confident in pitching and presenting patient-focused strategies, supporting new business initiatives, and building strong client relationships through excellent customer service.

She has actively participated in patient, site, and physician advisory boards and focus groups, translating insights into clear, actionable reports. Her therapy area experience is broad, covering cardiology, dermatology, gastroenterology, haematology, immunology, neuroscience, oncology, rare diseases, and women’s health.

Sarah holds a BA (Special Honours) in English with subsidiary Psychology from the University of Birmingham, UK.

Emilie Barré offers over 18 years of rich experience in clinical trials, blending her statistical expertise with seasoned project management skills. Throughout her career, including a significant period at BMS, Emilie has developed both the analytical and leadership aspects necessary for success in the field. Emilie’s approach centers on creating genuine partnerships with clients, striving to deeply understand and meet their needs. This dedication to client service, combined with her extensive background, enables her to lead projects that deliver meaningful and tailored healthcare solutions.

Natasha is a specialist in patient and public involvement in research. Her work is focused on embedding lived experiences from the earliest stages of research development, and supporting the development of purposeful, equitable, and sustainable partnerships with patients and communities to improve and maximise the impact of research.

Natasha joined medical research charity LifeArc in February 2024, where she leads on patient engagement initiatives and supports colleagues across the organisation to ensure LifeArc’s work is shaped by patients, communities and people with lived experience.

Natasha has extensive experience working with the charity sector, academia and industry, and previously led the Research Involvement programme at Parkinson’s UK. Natasha is also a visiting lecturer at King’s College London, working within the Centre for Pharmaceutical Medicine Research to advance research and education on patient engagement in medicines development.

Rachael Chandler is a Senior Medical Writer in the Patient Engagement and Policy team at Oxford PharmaGenesis, with specific expertise in neurodegenerative disease research. She partners with pharmaceutical, biotech and charity organisations to capture and apply the perspectives of patients, families and caregivers, ensuring that lived experience shapes research strategy and communications.

Rachael played a key role in the development and running of the Motor Neurone Disease Insights Initiative, in collaboration with LifeArc. Her work included evidence-based initiative design, collaborative creation of engagement activities, facilitating involvement and discussions, synthesising qualitative insights and translating patient experiences into outputs that inform research priorities and foster transparent dialogue between research and patient communities.

Rachael holds a PhD on the molecular basis of Parkinson’s disease, following a Parkinson’s UK PhD studentship, bringing a strong scientific foundation to the generation and application of insights.

At Oxford PharmaGenesis, Rachael works within their specialist Patient Engagement team. They offer holistic, authentic and science-led patient engagement services, contributing depth and diversity of expertise and innovation by compliantly and rigorously integrating representative insights and co-creating solutions. They ensure patient insights and experience data help to improve patient outcomes and impact clients' strategies and activities

Before joining myTomorrows, Nico held leadership roles at Clinigen and Marken, where he led Managed Access Services. At myTomorrows, he focuses on building strategic partnerships and supporting biopharma companies in developing patient access solutions that align with clinical development and market access goals. His work is centered on enabling earlier and more equitable access to treatment options for patients with unmet medical needs. 

LaQuinta Jernigan is Chief Commercial Officer at mdgroup, where she leads global commercial strategy and partnerships for patient-first clinical trial solutions. With extensive experience across the life sciences sector, LaQuinta brings a strong track record of building sustainable, high-impact partnerships that support sponsors and CROs in delivering more effective, patient-centered studies.

Her background spans both commercial and operational roles, giving her a well-rounded perspective on the complexities of modern clinical trials. She works closely with clients to understand their strategic goals and operational challenges, helping design tailored solutions that improve patient engagement, streamline delivery, and drive successful outcomes. LaQuinta is particularly focused on balancing speed, quality, and cost—ensuring studies remain efficient while keeping patient needs at the forefront.

Passionate about advancing the clinical trial experience, LaQuinta champions approaches that reduce barriers to participation and improve accessibility for diverse patient populations. She is a strong advocate for integrating personalized support services, digital innovation, and flexible trial models to better align research with real-world patient lives.

At mdgroup, LaQuinta is dedicated to strengthening collaboration across the clinical ecosystem—bringing together sponsors, CROs, healthcare providers, and patient communities to create more inclusive and effective research. She believes that meaningful progress in clinical trials comes from combining operational excellence with empathy, ensuring every patient is treated not just as a participant, but as a person at the center of the journey.

   TBD

  Sophie Copley is Co-founder and Chief Product Officer at Little Journey, creators of the Trial Flow platform. Specialising in human-centred healthcare design and user experience, she has received multiple awards in product design, demonstrating a strong track record of translating user insight into impactful digital products.

Bernard Chylinski is the Deputy Head Porter at one of the colleges of the University of Oxford, where he plays a key role in the day-to-day running of the college community. Before entering university life, Bernard had a diverse career, including time in the navy and as a musician—experiences that shaped his resilience, adaptability, and strong sense of teamwork.

In 2023, Bernard was diagnosed with stage three bowel cancer and underwent treatment as part of a clinical trial. His experience as a patient has given him a direct understanding of navigating complex care pathways and the importance of patient-centred innovation in healthcare.

Bernard is an active member of Shine Cancer Support, a charity dedicated to people in their 20s, 30s, and 40s living with cancer. Through this group he supports others facing the challenges of diagnosis, treatment, and life beyond cancer, offering empathy, encouragement, and practical insight.

He brings to the Patients as Partners EU conference a powerful perspective shaped by lived experience, a commitment to community, and a belief in the value of collaboration between patients and healthcare professionals.